Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
Melanotan II, an unregulated synthetic peptide used for tanning, stimulates melanin production and frequently causes existing moles to darken, new freckles to appear, and may obscure early warning signs of melanoma. Since product purity, dosing, and long-term effects remain unknown, any rapid change in a mole's size, shape, or color requires prompt medical evaluation.
Key steps include performing regular self-exams, scheduling routine dermatologist visits, and practicing sun-safe habits to protect your skin.
If you've noticed changes in your moles, unusual skin spots, or other symptoms after Melanotan II use, don't wait to find answers. A free, instant, online symptom check can help you evaluate your symptoms in minutes, identify possible causes, and guide your next steps—empowering you to have a more informed conversation with your doctor and act quickly if serious concerns arise.
Reviewed for medical accuracy: 07/09/2026
Melanotan II and Moles: Why Skin Changes & Medically Approved Next Steps
Melanotan II is a synthetic peptide that many people use to darken their skin tone without long hours in the sun. As its popularity grows—especially online—you may have questions about how it affects moles, why your skin changes, and what you should do next. This guide explains the key points in plain language, based on credible medical sources, and helps you decide on safe, medically approved steps.
Melanotan II mimics a natural hormone called alpha-melanocyte stimulating hormone (α-MSH). When you inject Melanotan II:
While some hope to avoid sunburn or achieve an even tan, Melanotan II is not approved by the FDA or most national health agencies. This means its safety, purity, and long-term effects aren't guaranteed.
Because Melanotan II boosts melanin production across all pigmented cells, it can affect existing moles (nevi) and sometimes trigger new pigmented spots:
Even though direct long-term studies on Melanotan II are limited, there are well-known risks when you alter pigmentation or stimulate melanocytes:
Regular self-exams and professional skin checks are your best defense against problematic changes. Use the ABCDE rule:
What to look for between dermatologist visits:
Stop Melanotan II Use
If you notice concerning changes, discontinue Melanotan II immediately. This removes the ongoing stimulus to your pigment cells.
Perform Monthly Self-Checks
Set a reminder to do a head-to-toe skin exam once a month under good lighting. Use a hand mirror or ask someone to help with hard-to-see areas (back, scalp).
Visit a Board-Certified Dermatologist
Schedule a professional skin check within four weeks if you see any ABCDE signs or sudden changes in your moles.
Consider Non-Invasive Monitoring
Technologies like dermoscopy (a special magnifying tool) help doctors evaluate moles more accurately without immediate biopsy.
Maintain Sun-Safe Habits
Track Your Moles
Taking clear, dated photos every month can help you and your doctor spot subtle changes over time.
Some changes require prompt evaluation, potentially even same-day:
If you experience these symptoms, do not wait for your next routine check-up.
Worried about changes in your moles or new skin spots? You can get personalized guidance right now by taking Ubie's free AI symptom checker—it takes just 3 minutes to assess your skin concerns, understand your risk level, and learn exactly what steps to take next before your dermatology appointment.
Nothing replaces an in-person evaluation by a qualified physician. If you notice any life-threatening or serious changes—such as a mole that bleeds uncontrollably or a rapidly expanding dark lesion—seek emergency care or call your healthcare provider right away.
Your skin health matters. While Melanotan II may seem like a shortcut to a sun-kissed glow, its unregulated nature and potential effects on moles mean you need to be vigilant. Monitor your skin closely, adopt sun-safe habits, and always involve a medical professional for anything unusual.
(References)
* Evans-Brown, M., et al. (2009). Melanotan II: A review of its use and associated adverse effects. *Drugs Today (Barc)*, *45*(11), 859-867. PMID: 20046903.
* Al-Saffar, A., et al. (2012). Recreational use of Melanotan II and development of multiple atypical moles and melanoma: a case series. *Journal of Cosmetic Dermatology*, *11*(4), 329-332. PMID: 23157790.
* Jørgensen, M. L., et al. (2013). Melanotan II-Induced Skin Lesions: A Report of Two Cases. *Skinmed*, *11*(6), 373-375. PMID: 24563969.
* O'Shea, S. J., et al. (2019). Melanotan II use leading to melanoma. *British Journal of Dermatology*, *180*(3), 679-680. PMID: 30146743.
* Nelson, L., et al. (2020). Melanotan II: An emerging health concern in the United States. *Journal of Medical Toxicology*, *16*(2), 245-249. PMID: 32249581.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.